Mucomyst

Allergic Rhinitis, Corneal Diseases, Sinusitis + 9 more
Treatment
10 Active Studies for Mucomyst

What is Mucomyst

AcetylcysteineThe Generic name of this drug
Treatment SummaryAcetylcysteine is a medication used to break up mucus and treat acetaminophen overdose. It has also been studied for other conditions, but the results have been mixed. This drug was approved by the FDA in 1963.
Acetylcysteineis the brand name
image of different drug pills on a surface
Mucomyst Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Acetylcysteine
Acetylcysteine
1989
41

Effectiveness

How Mucomyst Affects PatientsAcetylcysteine is used to treat mucus buildup and acetaminophen poisonings. It is usually taken 1-8 hours apart depending on the method of administration. Its side effects are generally not severe, but patients should be warned of the possibility of an allergic reaction or stomach bleeding. Acetylcysteine can have a strong unpleasant taste, so patients may need to mix it with soda for flavor.
How Mucomyst works in the bodyAcetylcysteine works in various ways to reduce mucous. It can break down the bonds that form thick mucous, reducing its viscosity. It also works to reduce the total amount of mucous produced. Additionally, it acts as an antioxidant, reducing the amount of molecules in the body that can cause cell damage. In cases of acetaminophen overdoses, acetylcysteine also helps protect cells by providing cysteine for glutathione production or by directly binding to toxic molecules that can cause cellular damage.

When to interrupt dosage

The recommended serving of Mucomyst is contingent upon the diagnosed condition, including Allergic Rhinitis, Airway secretion clearance therapy and Keratopathy. The quantity of dosage fluctuates as per the technique of delivery (e.g. Inhalant or Injection, solution) featured in the table beneath.
Condition
Dosage
Administration
Corneal Diseases
, 100.0 mg/mL, 200.0 mg/mL, 600.0 mg/mL, 500.0 mg, 2500.0 mg, 600.0 mg, 50.0 mg, 200.0 mg
Oral; Respiratory (inhalation), , Solution - Oral; Respiratory (inhalation), Solution, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Injection, Intravenous, Injection - Intravenous, Injection, solution - Intravenous, Injection, solution, Intravenous; Oral; Respiratory (inhalation), Solution - Intravenous; Oral; Respiratory (inhalation), Liquid - Intravenous; Oral; Respiratory (inhalation), Liquid, Liquid - Intravenous, Tablet, effervescent, Oral, Tablet, effervescent - Oral, Inhalant - Oral; Respiratory (inhalation), Tablet, Tablet - Oral, Capsule, Capsule - Oral, Capsule, extended release - Oral, Capsule, extended release, Tablet, coated, Tablet, coated - Oral
Sinusitis
, 100.0 mg/mL, 200.0 mg/mL, 600.0 mg/mL, 500.0 mg, 2500.0 mg, 600.0 mg, 50.0 mg, 200.0 mg
Oral; Respiratory (inhalation), , Solution - Oral; Respiratory (inhalation), Solution, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Injection, Intravenous, Injection - Intravenous, Injection, solution - Intravenous, Injection, solution, Intravenous; Oral; Respiratory (inhalation), Solution - Intravenous; Oral; Respiratory (inhalation), Liquid - Intravenous; Oral; Respiratory (inhalation), Liquid, Liquid - Intravenous, Tablet, effervescent, Oral, Tablet, effervescent - Oral, Inhalant - Oral; Respiratory (inhalation), Tablet, Tablet - Oral, Capsule, Capsule - Oral, Capsule, extended release - Oral, Capsule, extended release, Tablet, coated, Tablet, coated - Oral
Rhinitis
, 100.0 mg/mL, 200.0 mg/mL, 600.0 mg/mL, 500.0 mg, 2500.0 mg, 600.0 mg, 50.0 mg, 200.0 mg
Oral; Respiratory (inhalation), , Solution - Oral; Respiratory (inhalation), Solution, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Injection, Intravenous, Injection - Intravenous, Injection, solution - Intravenous, Injection, solution, Intravenous; Oral; Respiratory (inhalation), Solution - Intravenous; Oral; Respiratory (inhalation), Liquid - Intravenous; Oral; Respiratory (inhalation), Liquid, Liquid - Intravenous, Tablet, effervescent, Oral, Tablet, effervescent - Oral, Inhalant - Oral; Respiratory (inhalation), Tablet, Tablet - Oral, Capsule, Capsule - Oral, Capsule, extended release - Oral, Capsule, extended release, Tablet, coated, Tablet, coated - Oral
Rhinitis, Allergic
, 100.0 mg/mL, 200.0 mg/mL, 600.0 mg/mL, 500.0 mg, 2500.0 mg, 600.0 mg, 50.0 mg, 200.0 mg
Oral; Respiratory (inhalation), , Solution - Oral; Respiratory (inhalation), Solution, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Injection, Intravenous, Injection - Intravenous, Injection, solution - Intravenous, Injection, solution, Intravenous; Oral; Respiratory (inhalation), Solution - Intravenous; Oral; Respiratory (inhalation), Liquid - Intravenous; Oral; Respiratory (inhalation), Liquid, Liquid - Intravenous, Tablet, effervescent, Oral, Tablet, effervescent - Oral, Inhalant - Oral; Respiratory (inhalation), Tablet, Tablet - Oral, Capsule, Capsule - Oral, Capsule, extended release - Oral, Capsule, extended release, Tablet, coated, Tablet, coated - Oral
Corneal Diseases
, 100.0 mg/mL, 200.0 mg/mL, 600.0 mg/mL, 500.0 mg, 2500.0 mg, 600.0 mg, 50.0 mg, 200.0 mg
Oral; Respiratory (inhalation), , Solution - Oral; Respiratory (inhalation), Solution, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Injection, Intravenous, Injection - Intravenous, Injection, solution - Intravenous, Injection, solution, Intravenous; Oral; Respiratory (inhalation), Solution - Intravenous; Oral; Respiratory (inhalation), Liquid - Intravenous; Oral; Respiratory (inhalation), Liquid, Liquid - Intravenous, Tablet, effervescent, Oral, Tablet, effervescent - Oral, Inhalant - Oral; Respiratory (inhalation), Tablet, Tablet - Oral, Capsule, Capsule - Oral, Capsule, extended release - Oral, Capsule, extended release, Tablet, coated, Tablet, coated - Oral
Rhinitis, Vasomotor
, 100.0 mg/mL, 200.0 mg/mL, 600.0 mg/mL, 500.0 mg, 2500.0 mg, 600.0 mg, 50.0 mg, 200.0 mg
Oral; Respiratory (inhalation), , Solution - Oral; Respiratory (inhalation), Solution, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Injection, Intravenous, Injection - Intravenous, Injection, solution - Intravenous, Injection, solution, Intravenous; Oral; Respiratory (inhalation), Solution - Intravenous; Oral; Respiratory (inhalation), Liquid - Intravenous; Oral; Respiratory (inhalation), Liquid, Liquid - Intravenous, Tablet, effervescent, Oral, Tablet, effervescent - Oral, Inhalant - Oral; Respiratory (inhalation), Tablet, Tablet - Oral, Capsule, Capsule - Oral, Capsule, extended release - Oral, Capsule, extended release, Tablet, coated, Tablet, coated - Oral
Rhinitis
, 100.0 mg/mL, 200.0 mg/mL, 600.0 mg/mL, 500.0 mg, 2500.0 mg, 600.0 mg, 50.0 mg, 200.0 mg
Oral; Respiratory (inhalation), , Solution - Oral; Respiratory (inhalation), Solution, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Injection, Intravenous, Injection - Intravenous, Injection, solution - Intravenous, Injection, solution, Intravenous; Oral; Respiratory (inhalation), Solution - Intravenous; Oral; Respiratory (inhalation), Liquid - Intravenous; Oral; Respiratory (inhalation), Liquid, Liquid - Intravenous, Tablet, effervescent, Oral, Tablet, effervescent - Oral, Inhalant - Oral; Respiratory (inhalation), Tablet, Tablet - Oral, Capsule, Capsule - Oral, Capsule, extended release - Oral, Capsule, extended release, Tablet, coated, Tablet, coated - Oral
acetaminophen
, 100.0 mg/mL, 200.0 mg/mL, 600.0 mg/mL, 500.0 mg, 2500.0 mg, 600.0 mg, 50.0 mg, 200.0 mg
Oral; Respiratory (inhalation), , Solution - Oral; Respiratory (inhalation), Solution, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Injection, Intravenous, Injection - Intravenous, Injection, solution - Intravenous, Injection, solution, Intravenous; Oral; Respiratory (inhalation), Solution - Intravenous; Oral; Respiratory (inhalation), Liquid - Intravenous; Oral; Respiratory (inhalation), Liquid, Liquid - Intravenous, Tablet, effervescent, Oral, Tablet, effervescent - Oral, Inhalant - Oral; Respiratory (inhalation), Tablet, Tablet - Oral, Capsule, Capsule - Oral, Capsule, extended release - Oral, Capsule, extended release, Tablet, coated, Tablet, coated - Oral
Airway secretion clearance therapy
, 100.0 mg/mL, 200.0 mg/mL, 600.0 mg/mL, 500.0 mg, 2500.0 mg, 600.0 mg, 50.0 mg, 200.0 mg
Oral; Respiratory (inhalation), , Solution - Oral; Respiratory (inhalation), Solution, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Injection, Intravenous, Injection - Intravenous, Injection, solution - Intravenous, Injection, solution, Intravenous; Oral; Respiratory (inhalation), Solution - Intravenous; Oral; Respiratory (inhalation), Liquid - Intravenous; Oral; Respiratory (inhalation), Liquid, Liquid - Intravenous, Tablet, effervescent, Oral, Tablet, effervescent - Oral, Inhalant - Oral; Respiratory (inhalation), Tablet, Tablet - Oral, Capsule, Capsule - Oral, Capsule, extended release - Oral, Capsule, extended release, Tablet, coated, Tablet, coated - Oral
Corneal Ulcer
, 100.0 mg/mL, 200.0 mg/mL, 600.0 mg/mL, 500.0 mg, 2500.0 mg, 600.0 mg, 50.0 mg, 200.0 mg
Oral; Respiratory (inhalation), , Solution - Oral; Respiratory (inhalation), Solution, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Injection, Intravenous, Injection - Intravenous, Injection, solution - Intravenous, Injection, solution, Intravenous; Oral; Respiratory (inhalation), Solution - Intravenous; Oral; Respiratory (inhalation), Liquid - Intravenous; Oral; Respiratory (inhalation), Liquid, Liquid - Intravenous, Tablet, effervescent, Oral, Tablet, effervescent - Oral, Inhalant - Oral; Respiratory (inhalation), Tablet, Tablet - Oral, Capsule, Capsule - Oral, Capsule, extended release - Oral, Capsule, extended release, Tablet, coated, Tablet, coated - Oral
Allergic Rhinitis
, 100.0 mg/mL, 200.0 mg/mL, 600.0 mg/mL, 500.0 mg, 2500.0 mg, 600.0 mg, 50.0 mg, 200.0 mg
Oral; Respiratory (inhalation), , Solution - Oral; Respiratory (inhalation), Solution, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Injection, Intravenous, Injection - Intravenous, Injection, solution - Intravenous, Injection, solution, Intravenous; Oral; Respiratory (inhalation), Solution - Intravenous; Oral; Respiratory (inhalation), Liquid - Intravenous; Oral; Respiratory (inhalation), Liquid, Liquid - Intravenous, Tablet, effervescent, Oral, Tablet, effervescent - Oral, Inhalant - Oral; Respiratory (inhalation), Tablet, Tablet - Oral, Capsule, Capsule - Oral, Capsule, extended release - Oral, Capsule, extended release, Tablet, coated, Tablet, coated - Oral
Rhinitis
, 100.0 mg/mL, 200.0 mg/mL, 600.0 mg/mL, 500.0 mg, 2500.0 mg, 600.0 mg, 50.0 mg, 200.0 mg
Oral; Respiratory (inhalation), , Solution - Oral; Respiratory (inhalation), Solution, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Injection, Intravenous, Injection - Intravenous, Injection, solution - Intravenous, Injection, solution, Intravenous; Oral; Respiratory (inhalation), Solution - Intravenous; Oral; Respiratory (inhalation), Liquid - Intravenous; Oral; Respiratory (inhalation), Liquid, Liquid - Intravenous, Tablet, effervescent, Oral, Tablet, effervescent - Oral, Inhalant - Oral; Respiratory (inhalation), Tablet, Tablet - Oral, Capsule, Capsule - Oral, Capsule, extended release - Oral, Capsule, extended release, Tablet, coated, Tablet, coated - Oral

Warnings

Mucomyst Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Acetylcysteine may interact with Pulse Frequency
There are 20 known major drug interactions with Mucomyst.
Common Mucomyst Drug Interactions
Drug Name
Risk Level
Description
Revefenacin
Major
Acetylcysteine may decrease the excretion rate of Revefenacin which could result in a higher serum level.
Ambrisentan
Minor
The excretion of Ambrisentan can be decreased when combined with Acetylcysteine.
Asunaprevir
Minor
The excretion of Asunaprevir can be decreased when combined with Acetylcysteine.
Atorvastatin
Minor
The excretion of Atorvastatin can be decreased when combined with Acetylcysteine.
Atrasentan
Minor
The excretion of Atrasentan can be decreased when combined with Acetylcysteine.
Mucomyst Toxicity & Overdose RiskOverdosing on Acetylcysteine may cause vomiting, nausea, difficulty breathing, swelling around the eyes, and low blood pressure. Treatment should focus on relieving symptoms and providing supportive care. Dialysis may also be used to remove some of the drug from the bloodstream as it is partly bound to proteins.
image of a doctor in a lab doing drug, clinical research

Mucomyst Novel Uses: Which Conditions Have a Clinical Trial Featuring Mucomyst?

There are 48 active clinical trials investigating the potential of Mucomyst in providing relief from Sinusitis, acute Rhinitis and Keratopathy.
Condition
Clinical Trials
Trial Phases
acetaminophen
0 Actively Recruiting
Corneal Ulcer
0 Actively Recruiting
Corneal Diseases
1 Actively Recruiting
Not Applicable
Corneal Diseases
0 Actively Recruiting
Rhinitis
0 Actively Recruiting
Rhinitis, Vasomotor
0 Actively Recruiting
Sinusitis
2 Actively Recruiting
Not Applicable
Airway secretion clearance therapy
0 Actively Recruiting
Rhinitis, Allergic
0 Actively Recruiting
Allergic Rhinitis
0 Actively Recruiting
Rhinitis
0 Actively Recruiting
Rhinitis
3 Actively Recruiting
Not Applicable, Phase 2

Mucomyst Reviews: What are patients saying about Mucomyst?

5Patient Review
6/29/2008
Mucomyst for Prevention of Kidney Damage due to Contrast Media
I was also given mucomyst to prevent kidney damage from the use of lasix. This medicine was successful and my creatinine levels went back to normal.
4.7Patient Review
2/19/2014
Mucomyst for Bronchitis
My doctor prescribed this to me in order to prevent kidney damage from the dyes in my medication, but I also had bronchitis at the time. It really helped shorten the duration of my illness.
4Patient Review
1/25/2014
Mucomyst for An Increase in the Thickness of Lung Secretions
It was tough to find a pharmacy that could get this, and even then my insurance company made things more difficult with their pre-authorization requirement (which has never been necessary for any other prescriptions I've gotten).
2.7Patient Review
11/24/2009
Mucomyst for Prevention of Kidney Damage due to Contrast Media
The FDA hasn't yet recognized this treatment for kidney problems related to IV contrast injections.
2Patient Review
10/23/2013
Mucomyst for Prevention of Kidney Damage due to Contrast Media
I was very disappointed with both the pharmacy and drug company. The doctor ordered 20 ml, but we were forced to purchase 120 ml at a cost of $671. I believe this is stealing or fraud.
2Patient Review
11/19/2009
Mucomyst for An Increase in the Thickness of Lung Secretions
The after taste of this medication is incredibly unpleasant and made me feel nauseous.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about mucomyst

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What does Mucomyst smell like?

"The acetylcysteine molecule has sulfur, which can remind people of the smell of rotten eggs. This is normal and does not mean that the medication itself is bad."

Answered by AI

What is Mucomyst used for?

"The medication acetylcysteine is used to help break up mucus in the airways of people who have certain lung diseases. This helps the person clear the mucus from their lungs so that they can breathe more easily."

Answered by AI

What type of drug is Mucomyst?

"The drug Mucomyst, used to treat the symptoms of pulmonary disease and for diagnostic bronchoscopy, is available in generic form under the name Acetylcysteine Solution. It may be used alone or with other medications."

Answered by AI

Is mucinex and Mucomyst the same?

"The similarity in appearance and sound between the drug names Mucomyst and Mucinex is due to the fact that both names start with the same three letters. Even though the last letters of each name are quite different, if they are not written clearly, it may be difficult to tell them apart."

Answered by AI

Clinical Trials for Mucomyst

Image of Columbia University Irving Medical Center in New York, United States.

Nanodropper-Mediated Anesthetic for Eye Conditions

18+
All Sexes
New York, NY
The goal of this clinical trial is to compare the onset and duration of numbness of the surface of the eye following the administration of numbing drops, called proparacaine, using either a standard eye drop bottle or a "Nanodropper" adaptor. The Nanodropper is designed to administer smaller-sized drops, or microdrops. Participants will: 1. Complete a baseline eye exam. 2. Receive a numbing drop using a standard dropper in one eye and the Nanodropper in the other eye. 3. Have their eyes tested for numbness at specific time points (30 seconds, 1, 2, 5, and 10 minutes after getting the drops). 4. Tell the researchers if they feel pain during the eye sensation tests. 5. Complete a survey about their experience with the eyedrops and testing procedure. This study could help us find a way to use less medication while still effectively administering eye medications, potentially saving money and reducing medical waste.
Phase 4
Recruiting
Columbia University Irving Medical Center
Image of QHSLab in West Palm Beach, United States.

Digital Tools for Allergic Rhinitis

18 - 65
All Sexes
West Palm Beach, FL
This study aims to evaluate the effectiveness of digital tools in managing allergic rhinitis (AR) in primary care settings. AR is a common condition that affects many people's quality of life. The study will test whether digital tools, such as the QHSLab platform, can help patients better control their symptoms, improve adherence to treatment, and enhance overall well-being. The trial will compare two groups: one using standard care and the other using both standard care and digital tools. Participants will be monitored over 12 months, and the study will measure changes in symptom severity, treatment adherence, quality of life, and healthcare usage. The study will also gather feedback from patients and healthcare providers about their experience with the digital tools. The digital tools used in this study are designed to help patients manage their AR more effectively by providing regular symptom assessments, medication reminders, and personalized feedback based on their health data. This summary ensures the information is clear and straightforward for patients, families, and healthcare providers while maintaining compliance with IRB guidelines.
Waitlist Available
Has No Placebo
QHSLabQHSLab, Inc.
Have you considered Mucomyst clinical trials? We made a collection of clinical trials featuring Mucomyst, we think they might fit your search criteria.Go to Trials
Image of University of Texas Medical Branch in Galveston, United States.

RG-RV for Cat Allergy

18 - 60
All Sexes
Galveston, TX
This is a mechanistic, controlled, open-label, single-site study to evaluate the effects of RG-RV16 inoculation on airway mucosal gene expression and airway remodeling in 25 healthy controls (HC), in 25 allergic rhinitis subjects (AR) with cat dander allergy, and in 25 allergic asthmatic subjects (AA) with cat dander allergy. Three groups (HC, AR, and AA) will undergo screening to establish clinical history, will undergo pulmonary function testing (spirometry), and will have blood drawn for clinical characterization (IgE, , ImmunoCAP, CBC and differential), and for assessing the presence of existing neutralizing antibody against RV16. Only those who meet criteria will be permitted to continue into the interventional and run-out phases of the study.
Phase 2
Recruiting
University of Texas Medical BranchWilliam J. Calhoun, MD
Image of Queen Elizabeth II Health Science Center in Halifax, Canada.

Intranasal Capsaicinoid Spray for Allergic Rhinitis

18+
All Sexes
Halifax, Canada
Rhinitis is inflammation of the inside of the nose. Symptoms of rhinitis include itchiness, sneezing, and a "runny" nose (rhinorrhea). There are many different causes for rhinitis, including allergies, age, different irritants in the air, overacting nervous system, and others. Many current treatments for rhinitis are not helpful or are unable to be used for long periods of time. Capsaicin ("Kap-Sey-Uh-Sin") is a natural product that is found in many spicy foods, including hot peppers. This natural product has been used as a lotion to prevent pain, and scientists have found that it may reduce the symptoms of rhinitis when used as a spray in the nose. However, capsaicin is known to cause a burning sensation. This study is needed so we can figure out what doses of capsaicin cause this burning sensation, and to what level these doses cause discomfort. Capsaicin can also cause a small degree of tearing from the eyes when used as a spray in the nose, and can also cause the nose to become "runny" (rhinorrhea). When the safest dose of capsaicin spray is found, that dose can be used to treat people with rhinitis that is not getting better from standard treatments.
Waitlist Available
Has No Placebo
Queen Elizabeth II Health Science CenterS Mark Taylor, MD FRCSC
Have you considered Mucomyst clinical trials? We made a collection of clinical trials featuring Mucomyst, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security